Stock BLRX BIOLINERX LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart BioLineRx Ltd. Nasdaq

Equities

BLRX

US09071M2052

Market Closed - Nasdaq
Other stock markets
 01:30:00 01/06/2024 am IST 		5-day change 1st Jan Change
0.7456 USD -9.05% Intraday chart for BioLineRx Ltd. +8.85% -52.51%
30/05 BioLineRx Ltd Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications in Sickle Cell Disease CI
28/05 Transcript : BioLineRx Ltd., Q1 2024 Earnings Call, May 28, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
BIOLINERX LTD.
Bio Therapeutic Drugs
-9.05%+8.85%-52.51%-52.66%-86.05% 58.12M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. BLRX Stock
  4. BLRX Stock
  5. Charts BioLineRx Ltd.
  6. Comparison Chart